Delivery Order SPE2DR25D1053-SPE2DR26FV554
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,097.17 to AmerisourceBergen Drug Corp for the supply of Arimidex (1 mg tablets, 30-count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a subsidiary of parent company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Arimidex 1 mg tablets in a 30-count package. This firm fixed-price delivery order, valued at $9,475.20, is scheduled for completion by January 12, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a non-set-aside competitive award, demonstrating the contractor's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,057.74 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) with a completion deadline of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,250.41 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,790.08 to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for the supply of Arimidex 1 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by January 7, 2026. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a $27,773.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Arimidex 1 mg, with an ultimate completion date of January 12, 2026. This competitively awarded, non-set-aside contract was issued on January 9, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $6,591.89 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $6,125.90 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with performance in Conshohocken, Pennsylvania and completion targeted for December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.29 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 24, 2025, with completion expected by November 25, 2025. This is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $5,438.88 delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. The award, made on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger pharmaceutical supply contract vehicle. The pharmaceutical will be delivered to the company's corporate office location in...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV554Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,606.55 to Amerisourcebergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on January 14, 2026, with an ultimate completion date of January 15, 2026. This non-competitive, firm fixed-price delivery order will be performed at the contractor's location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. This delivery order is issued under Amerisourcebergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The underlying IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The DLA Troop Support Medical supply chain regularly leverages this contract vehicle to fulfill essential pharmaceutical requirements across the Department of Defense, Defense Health Agency, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/13/26 |